COVID-19

Seyyed Mohammad Matin Alavi-Dana1, Yazdan Gholami1, Mohammadreza Meghdadi2

  • 1Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Inflammopharmacology
|December 20, 2023
PubMed
概括

介质细胞干细胞 (MSC) 疗法通过减少炎症和细胞因子风暴来治疗COVID-19具有前景. 临床研究表明,MSC治疗是COVID-19感染患者的安全有效的新型治疗选择.